SEARCH

SEARCH BY CITATION

REFERENCES

  • 1
    Kinghorn WA, McEvoy JP. Aripiprazole: Pharmacology, efficacy, safety and tolerability. Expert Rev Neurother 2005; 5: 297307.
  • 2
    Pinninti NR, Mago R, Adityanjee . Tardive dystonia-associated prescription of aripiprazole. J Neuropsychiatry Clin Neurosci 2006; 18: 426427.
  • 3
    Sharma A, Sorrell JH. Aripiprazole-induced parkinsonism. Int Clin Psychopharmacol 2006; 21: 127129.
  • 4
    Zacher JL, Hatchett AD. Aripiprazole-induced movement disorder. Am J Psychiatry 2006; 163: 160161.
  • 5
    Desarkar P, Thakur A, Sinha VR. Aripiprazole-induced acute dystonia. Am J Psychiatry 2006; 163: 11121113.
  • 6
    Fountoulakis KN, Siamouli M, Kantartzis S, Panagiotidis P, Iacovides A, Kaprinis GS. Acute dystonia with low-dosage aripiprazole in Tourette's disorder. Ann Pharmacother 2006; 40: 775777.
  • 7
    De Deyn P, Jeste DV, Swanink R et al. Aripiprazole for the treatment of psychosis in patients with Alzheimer's disease: A randomized, placebo-controlled study. J Clin Psychopharmacol 2005; 25: 463467.
  • 8
    Kinghorn WA, McEvoy JP. Aripiprazole: Pharmacology, efficacy, safety and tolerability. Expert Rev Neurother 2005; 5: 297307.
  • 9
    Jakobsen KD, Hansen T, Werge T. Diagnostic stability among chronic patients with functional psychoses: and epidemiological and clinical study. BMC Psychiatry 2007; 7: 41.